Enpath Medical, Inc.
HCID Member | Medical Devices & Tech
2300 Berkshire Lane N
Minneapolis, MN 55441 USA
phone: 763.951.8181
fax: 763.559.0148
Symbol NPTH
Exchange Nasdaq
Founded 1981
Employees 260
www.enpathmedical.com
Research Sector Medical Devices & Tech
Summary Description
Specialized devices for cardiac rhythm management, neuromodulation and interventional radiology markets
Management
John C. Hertig, Chief Executive Officer; Mark C. Kraus, Vice President & General Manager of Introducers; David A. Grenz, Vice President & General Manager of Stimulation Leads; James M. Reed, Vice President & General Manager of Advanced Delivery Systems; Michael D. Erdmann, Corporate Controller and Corporate Secretary; Steven D. Mogensen, Vice President of Sales & Marketing; Mike Winegar, Vice President of Regulatory Affairs and Quality Assurance; Scott P. Youngstrom, Vice President of Finance, Chief Financial Officer
Ownership
Financials


* numbers in thousands

 
Keywords
Cardiovascular, cardiology, Cardiology, cardiac, heart, rhythm, venous, vessel, introducers, leads, stents, Cardiology, cardiac, heart rhythm management, crm, neuromodulation, interventional, radiology, percutaneous, percutaneous delivery systems, stimula

Comment | Printable Version | Aug. 20, 2008
If you work for Enpath Medical, Inc. and want to update this profile, click here

Description
Enpath Medical develops, manufactures and markets percutaneous vessel introducers, implantable stimulation leads, steerable catheter delivery systems and accessories for the cardiac rhythm management (CRM), neuromodulation and interventional radiology markets. The company also manufactures medical devices and components for other medical product companies on a contract basis.
Products / Services
Enpath Medical develops and manufactures its own product line of implantable pacing leads, lead adapters, lead delivery systems, and venous introducers. Enpath manufactures delivery systems that solve procedural difficulties and enable safe, simple delivery of therapeutic and diagnostic devices.
Technology / Differentiation
Enpath offers a family of percutaneous venous vessel introducers that enable physicians to create a conduit through which they insert infusion catheters, implantable ports, pacemaker leads, and other therapeutic devices into a blood vessel.
Market / Customers
The company serves various customers in the cardiac rhythm management, neuromodulation, and interventional radiology markets.
Competitors / Substitutes / Alternatives
Baxter International Inc., Guidant Corporations (subsidiary or division), St. Jude Medical Inc.
Strategy
Enpath Medical has partnered with start-up companies and major OEMs to develop and manufacture new lead designs that can be used in pre-clinical research, regulated clinical studies and high-volume commercial release. Enpath has also developed capabilities in designing and manufacturing more sophisticated steerable sheaths (deflectable catheters) for both venous and arterial procedures, enabling physicians to more easily reach difficult anatomic locations with existing therapeutic and imaging devices.
Status
Enpath Medical has been supplying implantable pacemaker leads to the CRM market since 1989 and holds a number of patents relating to pacing leads and implant tools. The company has been successfully partnering in the development and manufacture of implantable stimulation leads for OEM customers in the field of Neuromodulation since mid-1990.


2008-08-27-2861